K150850 is an FDA 510(k) clearance for the Refobacin Bone Cement R. This device is classified as a Bone Cement, Antibiotic (Class II - Special Controls, product code MBB).
Submitted by Biomet, Inc. (Warsaw, US). The FDA issued a Cleared decision on July 16, 2015, 107 days after receiving the submission on March 31, 2015.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3027.
| 510(k) Number | K150850 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | March 31, 2015 |
| Decision Date | July 16, 2015 |
| Days to Decision | 107 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MBB — Bone Cement, Antibiotic |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 888.3027 |